Institution statistics - MEDICAL BIOTECHNOLOGY

INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE (INSERM) - France 

Ranking results:

Past rankings:
Subject specific rankings are not yet available..
Ranking timeline:

European project participation (2000-01-01 - 2020-12-31 MEDICAL BIOTECHNOLOGY):

Performance:

Funding:

Total funding allocated to projects this organisation participated or coordinated

Funding per Partner:

Since 2014 individual funding per partner. If data is not available at CORDIS: total funding / No of participants.

Projects:
Leadership:

Total number of projects: 68
As coordinator: 15
As participant: 52
Sole participant: 1
Coordinator / Participant Ratio: 0.29*

*Ratio includes only projects with > 2 partners

Summary:
Total project funding [€]:Projects [No]:
Year:coordinator*participant*per partner  as coordinatoras participant
2019 0 5.404.699 566.250 2
2013 1.500.000 0 1.500.000 1
2011 17.661.362 76.019.751 11.529.201 4 12
2010 37.579.100 129.016.774 17.156.484 6 24
2009 20.117.421 42.605.323 4.294.823 3 7
2008 2.999.879 42.124.080 3.785.053 1 7
2006 1.699.908 0 242.844 1
*n.b.: These numbers represent the total amount of funds allocated to projects this institution has participated in, not the funding allocated to this institution

Networking:

Partners:
Institution:Projects [No]:
CENTRE NATIONAL DE LA RECHERCHE SCIENTIFIQUE171
KAROLINSKA INSTITUTE139
UNIVERSITY COLLEGE LONDON120
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF OXFORD86
IMPERIAL COLLEGE OF SCIENCE TECHNOLOGY AND MEDICINE82
INSERM TRANSFERT76
KATHOLIEKE UNIVERSITEIT LEUVEN73
KING'S COLLEGE LONDON72
CHARITE UNIVERSITAETSMEDIZIN BERLIN65
MEDICAL RESEARCH COUNCIL63
THE CHANCELLOR MASTERS AND SCHOLARS OF THE UNIVERSITY OF CAMBRIDGE58
ERASMUS UNIVERSITAIR MEDISCH CENTRUM ROTTERDAM55
STICHTING KATHOLIEKE UNIVERSITEIT52
ASSISTANCE PUBLIQUE HOPITAUX DE PARIS51
UPPSALA UNIVERSITET51
COMMISSARIAT A L'ENERGIE ATOMIQUE50
EUROPEAN MOLECULAR BIOLOGY LABORATORY50
INSTITUT PASTEUR50
GSF FORSCHUNGSZENTRUM FUER UMWELT UND GESUNDHEIT43
MEDIZINISCHE UNIVERSITAET WIEN42
UNIVERSITY OF COPENHAGEN42
ISTITUTO SUPERIORE DI SANITA40
LEIDEN UNIVERSITY MEDICAL CENTER40
UNIVERSITY OF HELSINKI40
UNIVERSITY OF NEWCASTLE UPON TYNE40
CONSIGLIO NAZIONALE DELLE RICERCHE39
THE UNIVERSITY OF EDINBURGH38
THE UNIVERSITY OF MANCHESTER38
UNIVERSITE DE GENEVE38
CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS37
UNIVERSITAETSKLINIKUM HEIDELBERG37
UNIVERSITY OF GLASGOW36
LUDWIG MAXIMILIANS UNIVERSITAET MUENCHEN35
LUNDS UNIVERSITET35
UNIVERSITAETSKLINIKUM FREIBURG34
MAX PLANCK GESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV33
ECOLE POLYTECHNIQUE FEDERALE DE LAUSANNE32
FONDAZIONE CENTRO SAN RAFFAELE DEL MONTE TABOR32
UNIVERSITAIR MEDISCH CENTRUM UTRECHT32
ACADEMISCH ZIEKENHUIS GRONINGEN31
EBERHARD KARLS UNIVERSITAET TUEBINGEN31
ACADEMISCH MEDISCH CENTRUM BIJ DE UNIVERSITEIT VAN AMSTERDAM30
MEDIZINISCHE HOCHSCHULE HANNOVER29
UNIVERSITAET ZUERICH29
UNIVERSITA DEGLI STUDI DI MILANO28
UNIVERSITE CATHOLIQUE DE LOUVAIN28
UNIVERSITE LIBRE DE BRUXELLES28
UNIVERSITA DEGLI STUDI DI PADOVA26
UNIVERSITAET ULM26
EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH25
UNIVERSITEIT MAASTRICHT25
WEIZMANN INSTITUTE OF SCIENCE25
INSTITUTO DE SALUD CARLOS III24
UNIVERSITE DE LIEGE24
UNIVERSITY OF BIRMINGHAM24
UNIVERSITY OF DUNDEE24
DEUTSCHES KREBSFORSCHUNGSZENTRUM23
UNIVERSITE PIERRE ET MARIE CURIE PARIS VI23
UNIVERSITEIT GENT23
UNIVERSITEIT UTRECHT23
UNIVERSITY OF WALES CARDIFF23
GOETEBORGS UNIVERSITET22
REGION HOVEDSTADEN22
UNIVERSITY OF LEICESTER22
UNIVERSITY OF OSLO22
UNIVERSITY OF SOUTHAMPTON22
ACADEMISCH ZIEKENHUIS LEIDEN21
ISTITUTO DI RICERCHE FARMACOLOGICHE MARIO NEGRI21
MAXPLANCKGESELLSCHAFT ZUR FOERDERUNG DER WISSENSCHAFTEN EV21
QUEEN MARY AND WESTFIELD COLLEGE UNIVERSITY OF LONDON21
RUPRECHT KARLS UNIVERSITAET HEIDELBERG21
SERVICIO MADRILENO DE SALUD21
TARTU ULIKOOL21
TECHNISCHE UNIVERSITAET DRESDEN21
THE UNIVERSITY OF LIVERPOOL21
THE UNIVERSITY OF SHEFFIELD21
UNIVERSITA DEGLI STUDI DI TORINO21
UNIVERSITY OF BRISTOL21
CONSORCI INSTITUT D'INVESTIGACIONS BIOMEDIQUES AUGUST PI I SUNYER20
GENOME RESEARCH20
NATIONAL AND KAPODISTRIAN UNIVERSITY OF ATHENS20
UNIVERSITY OF BERGEN20
UNIVERSITY OF LEEDS19
HEINRICHHEINEUNIVERSITAET DUESSELDORF18
LEIDEN UNIVERSITY18
TEL AVIV UNIVERSITY18
UNIVERSITA DEGLI STUDI DI ROMA LA SAPIENZA18
UNIVERSITAET BERN18
VRIJE UNIVERSITEIT BRUSSEL18
AGENCIA ESTATAL CONSEJO SUPERIOR DE INVESTIGACIONES CIENTIFICAS17
PHILIPPS UNIVERSITAET MARBURG17
ST GEORGE'S HOSPITAL MEDICAL SCHOOL17
UNIVERSITAETSMEDIZIN GOETTINGEN GEORGAUGUSTUNIVERSITAET GOETTINGEN STIFTUNG OEFFENTLICHEN RECHTS17
UNIVERSITY OF AARHUS17
ACADEMISCH ZIEKENHUIS BIJ DE UNIVERSITEIT VAN AMSTERDAM16
ALBERT LUDWIGS UNIVERSITAET FREIBURG16
FRAUNHOFER GESELLSCHAFT ZUR FOERDERUNG DER ANGEWANDTEN FORSCHUNG E V16
KUNGLIGA TEKNISKA HOEGSKOLAN16
NATIONAL UNIVERSITY OF IRELAND GALWAY16
OSPEDALE PEDIATRICO BAMBINO GESU16
Constancy:

Total number of partners:11736

Partner loyalty:
Frequent Partner: (> 2 projects): 7676
Rare Partner: 4060

Frequent / Rare Partner Ratio: 1.89

Diversity:

Categories:
Category:No:
BIOLOGICAL SCIENCES577
RTD HORIZONTAL TOPICS389
SOCIAL AND ECONOMIC CONCERNS222
PROTECTING MAN AND HIS ENVIRON93
INDUSTRY AND TECHNOLOGY60
AGRICULTURE AND MARINE RESOURC21
ENERGY6
MEASUREMENTS AND STANDARDS3
PHYSICAL AND EXACT SCIENCES3

Project overview:

Start dateProjectacronymrolefundingpartners
2019-03-01RESTORE Health by Advanced Therapies (Advanced Therapy Medicinal Products and Biologized Medical Devices) – ALL for Advanced Therapies – with Passion – For Patients RESTOREparticipant1.000.00011
2019-01-01Exploring and Modifying the Sense of Time in Virtual Environments VIRTUALTIMESparticipant4.404.6996
2013-01-01The Structure and Assembly of Membrane Proteins in Native Membranes studied by AFM MEM-STRUCT-AFMcoordinator1.500.0001
2011-07-01APL a model for oncogene-targeted leukemia cure STEMAPLparticipant2.500.0002
2011-04-01Adaptive and innovative Radiation Treatment FOR improving Cancer patients treatment outcomE ARTFORCEparticipant5.994.71514
2011-03-01Phase I/II ex vivo gene therapy clinical trial for recessive dystrophic epidermolysis bullosa using skin equivalent grafts genetically corrected with a COL7A1-encoding SIN retroviral vector GENEGRAFTcoordinator4.961.65410
2011-03-01European collaborative project on Targeted therapy in renal cell cancer: genetic and tumor-related biomarkers for response and toxicity EuroTARGETparticipant5.999.55015
2011-02-01Prevention of Liver Fibrosis and Cancer in Africa PROLIFICAparticipant3.000.0008
2011-02-01More Medicines for Tuberculosis MM4TBparticipant11.873.05225
2011-01-01Stem Cells for Relevant Efficient Extended and Normalized Toxicology SCR&TOXcoordinator4.700.00015
2011-01-01European Network for the Study of Adrenal Tumours - Structuring clinical research on adrenal cancers in adults ENS@T-CANCERparticipant5.993.97816
2011-01-01Open Collaborative Model for Tuberculosis Lead Optimisation ORCHIDparticipant5.357.42914
2011-01-01Effective Perinatal Intensive Care in Europe: translating knowledge into evidence based practice EPICEcoordinator2.999.70813
2011-01-01Immunoglobulin IgY pseudomonas A clinical trial for cystic fibrosis treatment IMPACTTparticipant5.376.18010
2011-01-01Genetic testing in Europe - Network for the further development, harmonization, validation and standardization of services EuroGentest2participant1.996.98922
2011-01-01Treat Infections in NeoNates 2 - Evaluation of an infective agent (azithromycin) for the treatment of infections in preterm and term neonates TINN2coordinator5.000.00016
2011-01-01Treatment of reperfusion injury using a mitochondrial targeted approach: towards a better understanding of the disease MITOCAREparticipant5.990.95917
2011-01-01Global Research in Paediatrics GRiPparticipant10.000.00023
2011-01-01Systems biology of liver cancer: an integrative genomic-epigenomic approach MODHEPparticipant11.936.89918
2010-12-01"Fungi in the setting of inflammation, allergy and autoimmune diseases:Translating basic science into clinical practices" ALLFUNparticipant5.524.70414
2010-12-01Biobank Standardisation and Harmonisation for Research Excellence in the European Union BioSHaRE-EUparticipant11.998.15217
2010-12-01PREvention of Late Stent Thrombosis by an Interdisciplinary Global European effort PRESTIGEparticipant5.979.64215
2010-12-01Mechanisms of the Development of ALLergy MEDALLcoordinator11.990.93923
2010-11-01"Spontaneous clearance in Patients acutely infected with HCV - Immune profiling, Novel biomarkers and X-omics approaches" SPHINXparticipant2.989.91010
2010-11-01Genomic predictors and oncogenic drivers in hepatocellular carcinoma HEPTROMICparticipant2.999.47810
2010-11-01FRAILTY OPERATIVE DEFINITION-CONSENSUS CONFERENCE FOD-CCparticipant487.0344
2010-11-01Suicidality: Treatment Occurring in Paediatrics STOPparticipant3.000.00019
2010-11-01Attention Deficit Hyperactivity Disorder Drugs Use Chronic Effects ADDUCEparticipant2.999.56017
2010-11-01Host and viral factors in acute hepatitis C HepaCuteparticipant2.999.50017
2010-11-01Advanced Cell-based Therapies for the treatment of Primary ImmunoDeficiency CELL-PIDparticipant11.887.73520
2010-10-01Epigenetics towards systems biology EPIGENESYSparticipant11.995.02428
2010-10-01Sharing capacity across Europe in high-throughput sequencing technology to explore genetic variation in health and disease GEUVADISparticipant2.000.00017
2010-10-01ERA-Net on Rare Diseases E-Rare-2coordinator1.999.68018
2010-10-01Management of Hypotension In the Preterm Extremely Low Gestational Age Newborn The HIP Trialparticipant5.355.32216
2010-10-01New Algorithms for Host Pathogen Systems Biology SYSPATHOparticipant2.942.42511
2010-09-01Gene Activated Matrices for Bone and Cartilage Regeneration in Arthritis GAMBAparticipant3.198.8499
2010-05-01European Friedreich's Ataxia Consortium for Translational Studies EFACTSparticipant5.983.37915
2010-04-01European Project on Mendelian Forms of Parkinson’s Disease MEFOPAparticipant5.759.46823
2010-04-01Dosimetry and Health Effects of Diagnostic Applications of Radiopharmaceuticals with particular emphasis on the use in children and adolescents PEDDOSE.NETparticipant499.5815
2010-03-01Therapeutic challenge in Leukodystrophies: Translational and ethical research towards clinical trials LeukoTreatparticipant5.978.12625
2010-03-01Rod-derived Cone Viability Factor RDCVFcoordinator2.623.3335
2010-02-01"Fighting blindness of Usher syndrome: diagnosis, pathogenesis and retinal treatment (TreatRetUsher)" TREATRUSHparticipant6.000.00013
2010-01-01INtegrated HEart Research In TrANslational genetics of dilated Cardiomyopathies in Europe INHERITANCEparticipant2.870.79111
2010-01-01Mechanisms of retrotransposition in humans and consequences on cancer genomic plasticity RETROGENOMICSparticipant1.874.0001
2010-01-01Beta Cell Therapy in Diabetes BETACELLTHERAPYparticipant11.700.00018
2010-01-01Schistosoma Epigenetics - Targets, Regulation, New Drugs SEtTReNDcoordinator3.299.9989
2010-01-01NEURAL TRANSPLANTATION IN THE TREATMENT OF PATIENTS WITH PARKINSON’S DISEASE TRANSEUROparticipant11.994.09515
2010-01-01The role of intestinal microflora in non-alcoholic fatty liver disease (NAFLD) FLORINASHcoordinator5.729.8106
2010-01-01Regenerating Bone defects using New biomedical Engineering approaches REBORNEcoordinator11.935.34024
2009-12-01Myasthenias, a group of immune mediated neurological diseases: from etiology to therapy FIGHT-MGcoordinator5.917.42112

overview shows latest 50 from 68 projects (2000-01-01 - 2020-12-31)
A full list of projects can be found here:

Alias institution names:
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE INSERM
  • INSTITUT NATIONAL DE LA SANTE ET DE LA RECHERCHE MEDICALE UNITE DE RECHERCHE 515 HOPITAL SAINTANTOINE

Data provision: © European Union; Source: CORDIS, http://cordis.europa.eu/ | This page is not provided by the European Commission see:Impressum